ID27765A - Plester gel yang mengandung steroid dan proses pembuatannya - Google Patents

Plester gel yang mengandung steroid dan proses pembuatannya

Info

Publication number
ID27765A
ID27765A IDW20010302A ID20010302A ID27765A ID 27765 A ID27765 A ID 27765A ID W20010302 A IDW20010302 A ID W20010302A ID 20010302 A ID20010302 A ID 20010302A ID 27765 A ID27765 A ID 27765A
Authority
ID
Indonesia
Prior art keywords
steroid
plester
gel
making
blended
Prior art date
Application number
IDW20010302A
Other languages
English (en)
Inventor
Kazunori Muta
Seiichiro Tsuru
Taro Yamahata
Original Assignee
Hisamitsu Pharmaceuticals Co I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceuticals Co I filed Critical Hisamitsu Pharmaceuticals Co I
Publication of ID27765A publication Critical patent/ID27765A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IDW20010302A 1998-07-10 1999-07-07 Plester gel yang mengandung steroid dan proses pembuatannya ID27765A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19593398A JP4456679B2 (ja) 1998-07-10 1998-07-10 ステロイド含有パップ剤及びその製造方法

Publications (1)

Publication Number Publication Date
ID27765A true ID27765A (id) 2001-04-26

Family

ID=16349396

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010302A ID27765A (id) 1998-07-10 1999-07-07 Plester gel yang mengandung steroid dan proses pembuatannya

Country Status (11)

Country Link
US (1) US6432431B1 (id)
EP (1) EP1097712B1 (id)
JP (1) JP4456679B2 (id)
KR (1) KR20010072664A (id)
CN (1) CN1308537A (id)
AT (1) ATE250930T1 (id)
BR (1) BR9912024A (id)
DE (1) DE69911788T2 (id)
ES (1) ES2209456T3 (id)
ID (1) ID27765A (id)
WO (1) WO2000002563A1 (id)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3655781B2 (ja) * 1999-08-25 2005-06-02 帝國製薬株式会社 ビタミンｃ又はその誘導体を配合したパップ剤
JP5300038B2 (ja) * 2000-03-07 2013-09-25 株式会社 資生堂 皮膚外用剤
AU5673901A (en) * 2000-05-15 2001-11-26 Hisamitsu Pharmaceutical Co., Inc. Sheet-type packs
CN1431906A (zh) * 2000-05-31 2003-07-23 日绊株式会社 透皮吸收型甾体外用药
AU2001264256B2 (en) * 2000-06-13 2006-05-11 Hisamitsu Pharmaceutical Co, Inc Plaster
DE10260873A1 (de) 2002-12-23 2004-07-15 Beiersdorf Ag Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
US7993654B2 (en) * 2002-12-23 2011-08-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract
DE10260872B4 (de) * 2002-12-23 2013-09-26 Beiersdorf Ag Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices
NZ541543A (en) * 2003-01-28 2008-02-29 Teikoku Seiyaku Kk Thin aqueous cataplasm having a support and a pressure-sensitive adhesive layer
JP4744439B2 (ja) * 2004-04-28 2011-08-10 久光製薬株式会社 貼付剤
EP1757309B1 (en) * 2004-04-28 2013-04-10 Hisamitsu Pharmaceutical Co., Inc. Adhesive material
JP4824336B2 (ja) * 2004-05-07 2011-11-30 ロート製薬株式会社 皮膚外用剤
JP4824337B2 (ja) * 2004-05-07 2011-11-30 ロート製薬株式会社 皮膚外用剤
JP5025268B2 (ja) * 2004-11-10 2012-09-12 久光製薬株式会社 外用製剤及び貼付剤
CN103830179B (zh) * 2014-03-24 2015-11-18 段懿玲 一种含有克罗米通的外用制剂及其制备工艺
CN104984385B (zh) * 2015-07-23 2017-08-29 山东维赫生物科技有限公司 一种水溶性医用预粘剂
WO2019189756A1 (ja) * 2018-03-30 2019-10-03 ロート製薬株式会社 外用油性固形組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5842168B2 (ja) * 1974-12-20 1983-09-17 トウコウヤクヒンコウギヨウ カブシキガイシヤ 局所用剤の製造方法
JPS5850964B2 (ja) * 1978-03-07 1983-11-14 東興薬品工業株式会社 ステロイド含有クリ−ム製剤およびその製造方法
JPS58225009A (ja) * 1982-06-23 1983-12-27 Shionogi & Co Ltd コルチコステロイド外用製剤
JPH0236572B2 (ja) * 1984-11-13 1990-08-17 Hokuriku Pharmaceutical Suteroidoo177monoesuteruganjukuriimuzai
JPS6351330A (ja) * 1986-08-20 1988-03-04 Teikoku Seiyaku Kk ステロイド剤含有外用貼付剤
JPS63201119A (ja) * 1987-02-17 1988-08-19 Kao Corp 貼付剤組成物
JPH0676327B2 (ja) * 1987-04-14 1994-09-28 株式会社大塚製薬工場 ステロイド軟膏製剤
JPH05271077A (ja) * 1992-03-25 1993-10-19 Lion Corp パップ剤
JP3029964B2 (ja) * 1993-01-20 2000-04-10 久光製薬株式会社 ステロイド類溶解剤及びステロイド類を主剤とする外用液剤
JP2860748B2 (ja) * 1993-12-24 1999-02-24 エスエス製薬株式会社 安定な酪酸ヒドロコルチゾン含有クリーム剤
JPH0853354A (ja) 1994-08-11 1996-02-27 Hisamitsu Pharmaceut Co Inc 皮膚疾患用水性貼付剤
EP0787488A4 (en) * 1994-11-18 1998-06-03 Hisamitsu Pharmaceutical Co TRANSDERMAL ABSORBABLE PLASTER

Also Published As

Publication number Publication date
WO2000002563A1 (fr) 2000-01-20
EP1097712B1 (en) 2003-10-01
EP1097712A1 (en) 2001-05-09
US6432431B1 (en) 2002-08-13
DE69911788T2 (de) 2004-05-06
ATE250930T1 (de) 2003-10-15
JP4456679B2 (ja) 2010-04-28
JP2000026299A (ja) 2000-01-25
DE69911788D1 (de) 2003-11-06
BR9912024A (pt) 2001-05-29
CN1308537A (zh) 2001-08-15
EP1097712A4 (en) 2002-05-02
ES2209456T3 (es) 2004-06-16
KR20010072664A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
ID27765A (id) Plester gel yang mengandung steroid dan proses pembuatannya
CA2366702A1 (en) Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
ES2117052T3 (es) Induccion de respuestas de linfocitos t citotoxicos.
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
WO1999064059A3 (en) Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
ATE413179T1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
CO4910133A1 (es) Antagonistas de 5-h[1f]
WO1999043361A8 (en) Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
EP0861663A3 (en) Osteoclastgenic inhibitory agent comprising interleukin-18
BR0011174A (pt) Composições, compostos, compostos isolados e métodos para controlar pestes
EP1238587A3 (en) Biopesticide compositions
DE69940051D1 (de) Wasserlösliche trockene zusammensetzungen
ES2133918T3 (es) Nuevos esteroides seco-d activos en el sistema cardiovascular y composiciones farmaceuticas que los contienen.
BG106368A (en) Pharmaceutical composition and its preparation
WO2000009071A3 (en) A novel liposomal formulation useful in treatment of cancer and other proliferation diseases
TR199701335T1 (xx) Diatomlu toprak ha�erat bile�imi
AU3315200A (en) 1,5-anhydro-d-fructose substituted with a hydrophobic group for use as anti-oxidant and/or emulsifier
GR3032271T3 (en) Method and agent for the control of insects
AR026756A1 (es) Nuevas combinaciones terapeuticas (s)-2-bencilamino-metil)-2,3,8,9-tetrahidro-7h-1,4-dioxino[2,3-e]indol-8-ona y neuroleticos para el tratamiento oprevencion de desordenes psicoticos
MXPA97008488A (es) Composicion fosfolipida procedimiento para la preparacion de tal composicion y aplicacion de la misma.